Today’s Guest: Robin Thurston | CEO of Helix Greg and Robin break down the differences between genotyping and next-gen sequencing, how we move beyond genealogy-only use cases, and why that distinction is so important for impacting value for patients and consumers. […]
DataPoint Podcast
Hospitals’ secret weapon against competitors like Google and Amazon – A conversation with Carrie Liken of Yext
Today’s Guest: Carrie Liken | Head of Healthcare at Yext Greg and Carrie talk about the fact that healthcare companies already have incredibly rich data about their patients, but aren’t necessarily thinking about how to break down their internal information […]
How AI-fueled academic/commercial partnerships are revolutionizing important health innovations – a conversation with Rachael Callcut, MD
Today’s Guest: Rachael Callcut, MD | Trauma surgeon; Program Director of the Smarter Health Artificial Intelligence Initiative at UCSF’s Center for Digital Health Innovation Greg and Rachael talk about how UCSF’s Center for Digital Health Innovation and the Smarter Health […]
Making sure that access to data actually improves patient care – a conversation with Luis Saldaña, MD
Today’s Guest: Luis Saldaña, MD | Chief Medical Informatics Officer at Texas Health Resources Greg and Luis unpack the successful integration of new data and technology into clinician workflow and ensure that it’s adding value to both the patient and the […]
Why health technology has to be deeply aligned with patient care – a conversation with Ed Marx
Today’s Guest: Ed Marx | Chief Information Officer at the Cleveland Clinic Greg and Ed talk about how even simple things like changing the language we use in Health IT impact the quality and relevance of work that we do, and […]
How One Drop is bringing comprehensive & data-driven diabetes management solutions to everyone – a conversation with Jeff Dachis
Today’s Guest: Jeff Dachis | Founder and CEO of One Drop Greg speaks with Jeff Dachis about the waste inherent in the diabetes marketplace, the lack of solutions for people with Type 2 diabetes, why a consumer-facing company has done so […]